Glenmark shares among top gainers on Nifty Midcap 150; surge 14.41%

In Friday's trading session, Glenmark shares surged 14.41%, reaching Rs 2,178.30 and emerging as one of the top gainers on the Nifty Midcap 150 index. The stock demonstrated significant positive momentum in today's session.Glenmark Financial PerformanceGlenmark's financial performance reveals the following trends:Consolidated Quarterly Results

Here is a summary of the consolidated quarterly results:

HeadingMar 2024Jun 2024Sep 2024Dec 2024

Mar 2025RevenueRs 3,062.95 CroreRs 3,244.19 CroreRs 3,433.80 CroreRs 3,387.55 Crore

Rs 3,256.21 CroreNet Profit-Rs 1,214.27 CroreRs 340.24 CroreRs 354.49 CroreRs 348.03 Crore

Rs 4.38 CroreEPS-43.1812.0612.5512.33

0.16

The revenue for Glenmark saw fluctuations across the quarters, with a peak in September 2024 at Rs 3,433.80 Crore. Net profit showed significant recovery from a loss of Rs 1,214.27 Crore in March 2024 to a profit, though minimal, of Rs 4.38 Crore in March 2025.Consolidated Yearly Results

The consolidated yearly results are as follows:

Heading2021202220232024

2025RevenueRs 10,943.93 CroreRs 12,304.90 CroreRs 12,990.11 CroreRs 11,813.10 Crore

Rs 13,321.74 CroreNet ProfitRs 970.09 CroreRs 993.65 CroreRs 377.40 Crore-Rs 1,830.85 Crore

Rs 1,047.14 CroreEPS34.3833.3710.53-53.22

37.11BVPS250.36334.48348.70278.09

313.60ROE13.7310.363.13-19.13

11.83Debt to Equity0.660.400.460.13

0.25

From 2021 to 2025, Glenmark's revenue increased from Rs 10,943.93 Crore to Rs 13,321.74 Crore. The net profit saw a significant dip in 2024 at -Rs 1,830.85 Crore but recovered to Rs 1,047.14 Crore in 2025. The debt-to-equity ratio decreased from 0.66 in 2021 to 0.25 in 2025.Consolidated Yearly Income Statement

The consolidated yearly income statement shows the following data (Values in Crore):

Mar 2025Mar 2024Mar 2023Mar 2022

Mar 2021Sales13,32111,81312,99012,304

10,943Other Income113839316166

50Total Income13,43512,65313,30612,471

10,994Total Expenditure11,82912,10012,08810,732

9,258EBIT1,6065521,2181,739

1,735Interest207515349298

353Tax3521,867491447

412Net Profit1,047-1,830377993

970

Glenmark Corporate Actions

Glenmark has been actively involved in corporate actions. Recent announcements include analyst/investor meetings and press releases regarding Ichnos Glenmark Innovation's (IGI) global commercialization strategy and an exclusive global licensing agreement with AbbVie for ISB 2001.

The company has a history of dividend payouts, with final dividends announced each year. For instance, a final dividend of Rs 2.50 per share (250%) was announced on May 24, 2024, with an effective date of September 13, 2024.

Additionally, Glenmark had a bonus issue on January 6, 2005, with a bonus ratio of 1:1 and an ex-bonus date of March 4, 2005. The company also underwent stock splits, including one on June 11, 2007, where the face value changed from Rs 2 to Rs 1, and another on July 31, 2003, where the face value changed from Rs 10 to Rs 2.With a robust trading session and positive momentum, Glenmark is showing very bullish sentiment as per Moneycontrol analysis.